Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    July 2018
  1. SEKINE K, Hamaguchi T, Shoji H, Takashima A, et al
    Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience.
    Oncology. 2018 Jul 20:1-9. doi: 10.1159/000489665.
    PubMed     Text format     Abstract available


    March 2018
  2. TANIOKA H, Miyamoto Y, Tsuji A, Asayama M, et al
    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
    Oncology. 2018 Mar 7. pii: 000486624. doi: 10.1159/000486624.
    PubMed     Text format     Abstract available


    January 2018
  3. PETRELLI F, Ardito R, Ghidini A, Zaniboni A, et al
    Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.
    Oncology. 2018 Jan 23. pii: 000486338. doi: 10.1159/000486338.
    PubMed     Text format     Abstract available


  4. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.
    Oncology. 2018;94:167-175.
    PubMed     Text format     Abstract available


  5. DE FELICE F, Martinetti MT, Orelli S, Bulzonetti N, et al
    Definitive Chemoradiotherapy for Anal Carcinoma: Long-Term Results Based on Consistent Time-to-Event Endpoints.
    Oncology. 2018;94:25-30.
    PubMed     Text format     Abstract available


    September 2017
  6. CICERO G, De Luca R, Dieli F
    Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.
    Oncology. 2017 Sep 6. doi: 10.1159/000479112.
    PubMed     Text format     Abstract available


  7. KOMORI A, Taniguchi H, Hamauchi S, Masuishi T, et al
    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
    Oncology. 2017 Sep 2. doi: 10.1159/000479280.
    PubMed     Text format     Abstract available


    July 2017
  8. NOZAWA H, Ishihara S, Kawai K, Sasaki K, et al
    Brain Metastasis from Colorectal Cancer: Predictors and Treatment Outcomes.
    Oncology. 2017 Jul 13. doi: 10.1159/000478661.
    PubMed     Text format     Abstract available


    May 2017
  9. LARSEN FO, Markussen A, Nielsen D, Colville-Ebeling B, et al
    Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer.
    Oncology. 2017 May 23. doi: 10.1159/000475818.
    PubMed     Text format     Abstract available


    April 2017
  10. LIM KH, Lee HY, Park SB, Song SY, et al
    Feasibility of Modified FOLFOX in Elderly Patients Aged >/=80 Years with Metastatic Gastric Cancer or Colorectal Cancer.
    Oncology. 2017 Apr 27. doi: 10.1159/000471767.
    PubMed     Text format     Abstract available


  11. TSUKAMOTO M, Iinuma H, Yagi T, Matsuda K, et al
    Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Oncology. 2017;92.
    PubMed     Text format     Abstract available


    February 2017
  12. SAITO G, Sadahiro S, Kamata H, Miyakita H, et al
    Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Oncology. 2017 Feb 9. doi: 10.1159/000456075.
    PubMed     Text format     Abstract available


  13. HASEGAWA H, Taniguchi H, Mitani S, Masuishi T, et al
    Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
    Oncology. 2017 Feb 1. doi: 10.1159/000453336.
    PubMed     Text format     Abstract available


    January 2017
  14. NOZAWA H, Ishihara S, Kawai K, Hata K, et al
    Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases.
    Oncology. 2017;92:135-141.
    PubMed     Text format     Abstract available


  15. KASAGI Y, Oki E, Ando K, Ito S, et al
    The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.
    Oncology. 2017;92:48-54.
    PubMed     Text format     Abstract available


  16. KIM DW, Byer J, Kothari N, Mahipal A, et al
    EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
    Oncology. 2017;92:190-196.
    PubMed     Text format     Abstract available


  17. DELHORME JB, Severac F, Waissi W, Romain B, et al
    Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal Margin.
    Oncology. 2017;93:183-190.
    PubMed     Text format     Abstract available


  18. YAMADA M, Sakurai T, Komeda Y, Nagai T, et al
    Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.
    Oncology. 2017;93 Suppl 1:20-26.
    PubMed     Text format     Abstract available


  19. OGAWA S, Ishii T, Minaga K, Nakatani Y, et al
    The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers.
    Oncology. 2017;93 Suppl 1:43-48.
    PubMed     Text format     Abstract available


  20. SAKURAI T, Adachi T, Kono M, Arizumi T, et al
    Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy.
    Oncology. 2017;93 Suppl 1:27-29.
    PubMed     Text format     Abstract available


  21. KOMEDA Y, Kashida H, Sakurai T, Asakuma Y, et al
    Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification.
    Oncology. 2017;93 Suppl 1:49-54.
    PubMed     Text format     Abstract available


  22. OKAMOTO K, Watanabe T, Komeda Y, Kono T, et al
    Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors.
    Oncology. 2017;93 Suppl 1:35-42.
    PubMed     Text format     Abstract available


  23. SUZUKI T, Sadahiro S, Tanaka A, Okada K, et al
    A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Oncology. 2017;93:287-294.
    PubMed     Text format     Abstract available


    December 2016
  24. YANG CA, Huang HY, Chang YS, Lin CL, et al
    DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
    Oncology. 2016;92.
    PubMed     Text format     Abstract available


  25. ALDIAB A, Al Khayal KA, Al Obaid OA, Alsheikh A, et al
    Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia.
    Oncology. 2016.
    PubMed     Text format     Abstract available


    October 2016
  26. ABE S, Kawai K, Ishihara S, Nozawa H, et al
    Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study.
    Oncology. 2016.
    PubMed     Text format     Abstract available


    August 2016
  27. PAOLICCHI E, Vivaldi C, De Gregorio V, Crea F, et al
    Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
    Oncology. 2016.
    PubMed     Text format     Abstract available


  28. SUGITA K, Kawakami K, Yokokawa T, Sugisaki T, et al
    Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.
    Oncology. 2016;91:224-230.
    PubMed     Text format     Abstract available


    July 2016
  29. AMAKI-TAKAO M, Yamaguchi T, Natsume S, Iijima T, et al
    Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.
    Oncology. 2016.
    PubMed     Text format     Abstract available


  30. NOZAWA H, Ishihara S, Kawai K, Murono K, et al
    Paradoxical Reductions in Serum Anti-p53 Autoantibody Levels by Chemotherapy in Unresectable Colorectal Cancer: An Observational Study.
    Oncology. 2016.
    PubMed     Text format     Abstract available


    June 2016
  31. SAITO G, Sadahiro S, Okada K, Tanaka A, et al
    Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
    Oncology. 2016.
    PubMed     Text format     Abstract available


    May 2016
  32. YOSHIDA M, Takagane A, Miyake Y, Shimada K, et al
    A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
    Oncology. 2016.
    PubMed     Text format     Abstract available


    January 2016
  33. CHOI EJ, Yoo NJ, Kim MS, An CH, et al
    Putative Tumor Suppressor Genes EGR1 and BRSK1 Are Mutated in Gastric and Colorectal Cancers.
    Oncology. 2016;91:289-294.
    PubMed     Text format     Abstract available


  34. KOHLER C, Marnitz S, Biel P, Cordes T, et al
    Successful Delivery in a 39-Year-Old Patient with Anal Cancer after Fertility-Preserving Surgery Followed by Primary Chemoradiation and Low Anti-Mullerian Hormone Level.
    Oncology. 2016;91:295-298.
    PubMed     Text format     Abstract available


  35. RUBIO I, Ibanez-Feijoo E, Andres L, Aguirre E, et al
    Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial Cancer.
    Oncology. 2016;91:171-6.
    PubMed     Text format     Abstract available


  36. KHAN AA, Akritidis G, Pring T, Alagarathnam S, et al
    The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer.
    Oncology. 2016;91:69-77.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: